CHORIORETINAL ATROPHY side effect
What is CHORIORETINAL ATROPHY ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
CHORIORETINAL ATROPHY and Recently Reported Side Effects
CHORIORETINAL ATROPHY and 15 most Active Side Effect polls
CHORIORETINAL ATROPHY and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Valtrex Side Effects Report #5648673-X
Physician from JAPAN reported VALTREX problem on Feb 28, 2008. Male patient, 56 years of age, was diagnosed with herpes zoster, peripheral vascular disorder, nerve injury, gastritis, insomnia, constipation and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, hallucination, visual, monoplegia, optic atrophy, scotoma, visual acuity reduced, visual field defect, . VALTREX dosage: 1000MG PER DAY. During the same period patient was treated with NICHI E NATE, FERROMIA, CYANOCOBALAMIN, TANKARU, AMOBAN, ALOSENN. Patient was hospitalized and became disabled. Patient recovered.
Valtrex Side Effects Report #5584270-2
VALTREX problem was reported by a Physician from JAPAN on Jan 07, 2008. Male patient, 56 years of age, was diagnosed with herpes zoster, peripheral vascular disorder, nerve injury, gastritis, insomnia, constipation and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, hallucination, visual, monoplegia, optic atrophy, scotoma, visual acuity reduced, visual field defect, . VALTREX dosage: 1000MG PER DAY. During the same period patient was treated with NICHI E NATE, FERROMIA, CYANOCOBALAMIN, TANKARU, AMOBAN, ALOSENN. Patient was hospitalized and became disabled. Patient recovered.
Valtrex Side Effects Report #5508774-3
Physician from JAPAN reported VALTREX problem on Nov 02, 2007. Male patient, 56 years of age, was diagnosed with herpes zoster, renal failure chronic, peripheral vascular disorder, anaemia, nerve injury, gastritis, insomnia, constipation and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, hallucination, visual, monoplegia, optic atrophy, scotoma, visual acuity reduced, visual field defect, . VALTREX dosage: 1000MG PER DAY. During the same period patient was treated with NICHI E NATE, FERROMIA, METHYCOBAL, TANKARU, AMOBAN, ALOSENN. Patient was hospitalized and became disabled. Patient recovered.
Visudyne Side Effects Report #5449576-6
VISUDYNE problem was reported by a Physician from JAPAN on Aug 24, 2007. Male patient, 54 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, disease progression, maculopathy, metamorphopsia, scotoma, visual acuity reduced, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5410329-6
Physician from JAPAN reported VISUDYNE problem on July 24, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, chorioretinal scar, choroidal neovascularisation, condition aggravated, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5410343-0
VISUDYNE problem was reported by a Physician from JAPAN on July 24, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5420056-7
Physician from JAPAN reported VISUDYNE problem on July 31, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, disease progression, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5420057-9
VISUDYNE problem was reported by a Physician from JAPAN on July 31, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, choroidal neovascularisation, disease progression, polypoidal choroidal vasculopathy, scar, visual acuity reduced, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401828-1
Physician from JAPAN reported VISUDYNE problem on July 11, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401845-1
VISUDYNE problem was reported by a Physician from JAPAN on July 11, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401828-1
Physician from JAPAN reported VISUDYNE problem on July 11, 2007. Male patient, 78 years of age, was diagnosed with polypoidal choroidal vasculopathy and was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . VISUDYNE dosage: unknown. Patient recovered.
Visudyne Side Effects Report #5401845-1
VISUDYNE problem was reported by a Physician from JAPAN on July 11, 2007. Male patient, 83 years of age, was treated with VISUDYNE. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . VISUDYNE dosage: unknown. Patient recovered.
Valtrex Side Effects Report #5778657-2
Physician from JAPAN reported VALTREX problem on June 11, 2008. Male patient, 56 years of age, was diagnosed with herpes zoster, peripheral vascular disorder, neuropathy peripheral, gastritis, insomnia, constipation and was treated with VALTREX. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, hallucination, visual, monoplegia, optic atrophy, scotoma, visual acuity reduced, visual field defect, . VALTREX dosage: 1000MG PER DAY. During the same period patient was treated with NICHI E NATE, FERROMIA, CYANOCOBALAMIN, TANKARU, AMOBAN, ALOSENN. Patient was hospitalized and became disabled. Patient recovered.
Bevacizumab Side Effects Report #5779412-X
BEVACIZUMAB problem was reported by a Physician from JAPAN on June 11, 2008. Female patient, 69 years of age, was diagnosed with choroidal neovascularisation and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . BEVACIZUMAB dosage: 1 MG, UNK. Patient recovered.
Bevacizumab Side Effects Report #5779421-0
Physician from JAPAN reported BEVACIZUMAB problem on June 11, 2008. Female patient, 73 years of age, was diagnosed with choroidal neovascularisation and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . BEVACIZUMAB dosage: 1 MG, UNK. Patient recovered.
Bevacizumab Side Effects Report #5779602-6
BEVACIZUMAB problem was reported by a Physician from JAPAN on June 11, 2008. Female patient, 63 years of age, was diagnosed with choroidal neovascularisation and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . BEVACIZUMAB dosage: 1 MG, UNK. Patient recovered.
Gabapentin Side Effects Report #5728086-2
Health Professional from UNITED KINGDOM reported GABAPENTIN problem on Apr 23, 2008. Female patient, 78 years of age, weighting 156.5 lb, was diagnosed with palindromic rheumatism and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, vision blurred, . GABAPENTIN dosage: unknown. During the same period patient was treated with ALENDRONATE, PREDNISOLONE, RANITIDINE, LEVOTHYROXINE. Patient recovered.
Gabapentin Side Effects Report #5729767-7
GABAPENTIN problem was reported by a Health Professional from UNITED KINGDOM on Apr 21, 2008. Female patient, 78 years of age, was diagnosed with palindromic rheumatism and was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, vision blurred, . GABAPENTIN dosage: 300 MG, PO. During the same period patient was treated with PREDNISOLONE, ALENDRONATE, LEVOTHYROXINE, RANITIDINE. Patient recovered.
Gabapentin Side Effects Report #5718711-4
Physician from UNITED KINGDOM reported GABAPENTIN problem on Apr 14, 2008. Female patient, 79 years of age, was treated with GABAPENTIN. After drug was administered, patient experienced the following problems/side effects: chorioretinal atrophy, . GABAPENTIN dosage: unknown. Patient recovered.